Previous 10 | Next 10 |
WALTHAM, MA / ACCESSWIRE / July 14, 2020 / EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) ("EyeGate" or "the Company"), a clinical-stage company focused on developing products for treating disorders of the eye, announced today that based on feedback from a meeting with the U.S. Food and Drug Ad...
WALTHAM, MA / ACCESSWIRE / June 11, 2020 / EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) ("EyeGate" or "the Company"), a clinical-stage company focused on developing products for treating disorders of the eye, announced today that it has received positive feedback from the U.S. Food and Drug A...
WALTHAM , MA / ACCESSWIRE / June 1, 2020 / EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) ("EyeGate" or "the Company"), a clinical-stage company focused on developing products for treating disorders of the eye, announced today that its Chief Executive Officer, Stephen From, will be presenting ...
WALTHAM, MA / ACCESSWIRE / May 6, 2020 / EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) ("EyeGate" or "the Company"), a clinical-stage company focused on developing products for treating disorders of the eye, today announced financial results for the quarter ended March 31, 2020 and provided an...
Gainers: Trevi Therapeutics (NASDAQ: TRVI ) +109% . More news on: Trevi Therapeutics, Inc., SG Blocks, Inc., Greenland Technologies Holding Corporation, Stocks on the move, , Read more ...
SG Blocks (NASDAQ: SGBX ) +100% on Q4 results .. More news on: SG Blocks, Inc., EyeGate Pharmaceuticals, Inc., Kiniksa Pharmaceuticals, Ltd., Stocks on the move, , Read more ...
Thinly traded nano cap EyeGate Pharmaceuticals (NASDAQ: EYEG ) jumps 71% premarket on increased volume in reaction to positive data from an investigator-masked 20-subject (40 eyes) study comparing its Ocular Bandage Gel (OBG) eye drop to Allergan's (NYSE: AGN ) Refresh Preserva...
WALTHAM, MA / ACCESSWIRE / March 31, 2020 / EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) ("EyeGate" or "the Company"), a clinical-stage company focused on developing products for treating disorders of the eye, announced today that it has received positive topline data in its study using the O...
Gainers : Rexahn Pharmaceuticals (NASDAQ: REXN ) +85% . More news on: Rexahn Pharmaceuticals, Inc., Sprint Corporation, Genprex, Inc., Stocks on the move, , Read more ...
EyeGate Pharmaceuticals (NASDAQ: EYEG ) hits the enrollment target in a follow-on pilot study evaluating its Ocular Bandage Gel eye drop in patients with punctate epitheliopathies, mainly dry eye. More news on: EyeGate Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, ...
News, Short Squeeze, Breakout and More Instantly...
Eyegate Pharmaceuticals Inc. Company Name:
EYEG Stock Symbol:
NASDAQ Market:
LONDON, UK / ACCESSWIRE / December 9, 2022 / Kazia Therapeutics has announced the publication of pre-clinical data for its second pipeline asset, EVT801 in the journal Cancer Research Communications. The research was conducted by licensing partner Evotec and was the key driver for Kazia in-licen...
LONDON, UK / ACCESSWIRE / December 7, 2022 / With its H123 interim results, ReNeuron highlighted progress across its proprietary exosome platform, CustomEx. The company reported H123 revenues of £438k (H122: £58k), primarily related to income associated with a £320k payment from F...
WALTHAM, Mass., Oct. 26, 2021 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG), (“EyeGate” or the “Company”), a clinical stage specialty pharmaceutical company developing and commercializing products for treating ophthalmic diseases, today announc...